If this is not your name, click here.
| | If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| |  Health Canada Approves Unadjuvanted H1N1 Vaccine OTTAWA, Ontario -- November 13, 2009 -- Health Canada has approved a unadjuvanted influenza A(H1N1) vaccine for protection against the H1N1 flu virus. Health Canada and the Public Health Agency of Canada are currently working with provincial and territorial governments to deliver the Canadian unadjuvanted H1N1 vaccine to health care facility sites to continue immunisation programs. “Health Canada’s authorisation was arrived at independently and on the basis of sound health science,” said Elwyn Griffiths, MD, General of the Biologics and Genetics Therapies Directorate, Health Canada, Ottawa, Ontario. “Canadians can be confident that this vaccine is both safe and effective. We firmly believe citizens should take advantage of the opportunity to protect themselves and members of their families from this virus.” The Chief Public Health Officer also noted that the Public Health Agency of Canada, Health Canada and the regulatory and public health agencies of other countries, are working together to ensure that appropriate control measures are in place to monitor the safety and effectiveness of the vaccine and to ensure the timely communication of any potential adverse events following immunisation. There is also a global commitment amongst regulatory authorities to rapidly share clinical and safety data on H1N1 vaccines and on any potential adverse events following immunisation. National recommendations on the use of the Canadian unadjuvanted H1N1 vaccine have been developed based on the latest scientific evidence, including clinical trial results.
SOURCE: Health Canada
|
